Catalyst Pharmaceuticals (CPRX)
(Real Time Quote from BATS)
$14.32 USD
+0.01 (0.07%)
Updated Dec 8, 2023 02:20 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Detailed Estimates
Estimates
Exp Earnings Date | 3/20/24 |
---|---|
Current Quarter | 0.46 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 0.00% |
ABR | 1.40 |
Earnings ESP
|
1.45% |
---|---|
Current Year | 1.69 |
Next Year | 2.39 |
EPS (TTM) | 0.57 |
P/E (F1) | 8.47 |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 105.27M | 102.02M | 392.63M | 453.82M |
# of Estimates | 5 | 3 | 5 | 5 |
High Estimate | 106.08M | 102.93M | 393.73M | 473.61M |
Low Estimate | 104.07M | 100.75M | 390.28M | 446.37M |
Year ago Sales | 60.76M | 85.37M | 214.20M | 392.63M |
Year over Year Growth Est. | 73.26% | 19.51% | 83.30% | 15.59% |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.46 | 0.54 | 1.69 | 2.39 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | 0.51 | 0.70 | 1.94 | 3.15 |
High Estimate | 0.51 | 0.70 | 1.94 | 3.15 |
Low Estimate | 0.43 | 0.43 | 1.05 | 2.05 |
Year ago EPS | 0.22 | 0.26 | 0.75 | 1.69 |
Year over Year Growth Est. | 109.09% | 107.69% | 125.33% | 41.42% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 2 | 1 | 1 |
Down Last 60 Days | 3 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | 0.46 | 0.54 | 1.69 | 2.39 |
7 Days Ago | 0.46 | 0.54 | 1.69 | 2.39 |
30 Days Ago | 0.49 | 0.50 | 1.52 | 2.25 |
60 Days Ago | 0.49 | 0.47 | 1.73 | 2.19 |
90 Days Ago | 0.49 | 0.47 | 1.73 | 2.17 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.47 | 0.54 | 1.90 | 2.47 |
Zacks Consensus Estimate | 0.46 | 0.54 | 1.69 | 2.39 |
Earnings ESP | 1.45% | 0.00% | 12.62% | 3.35% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | 0.33 | 0.26 | 0.22 | NA |
Estimate | -0.24 | 0.25 | 0.30 | 0.21 | NA |
Difference | 0.00 | 0.08 | -0.04 | 0.01 | 0.01 |
Surprise | 0.00% | 32.00% | -13.33% | 4.76% | 5.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more